Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.
Also called NCT05937854
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 126 participants
- Registry
-
NCT05937854
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05937854. Randomized; quadruple masking; primary purpose treatment. Start 2024-04-01 (actual); primary completion 2029-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Acronym
- BETTER COPD-PH
- Condition
- Chronic Obstructive Pulmonary Disease
- Condition
- Pulmonary Hypertension
- Condition
- Dyspnea
- Intervention (Drug)
- Tadalafil
- Intervention (Drug)
- Placebo
- Lead sponsor
- VA Office of Research and Development
- Collaborator
- VA Boston Healthcare System
- Collaborator
- Atlanta VA Medical Center
- Collaborator
- VA Eastern Colorado Health Care System
- Collaborator
- VA Nebraska Western Iowa Health Care System
Record details
- Record id
cardio:ct-nct05937854- Content hash
1da4d04c2863e0b90b1dd121804f70a5806844fb6b3cdf0624c17c1420240c34